Financials
- Market Capitalization 2.19 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-18.43
ratio cours/chiffre d'affaires
10.57
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1900 | KOD Kodiak Sciences Inc - Common Stock | 36.36 USD | -3.04% | -7.06% | -10.20% | +319.38% | 2.29 B USD | ||
| 1934 | MESO Mesoblast Limited - American Depositary Shares | 17.14 USD | -0.87% | -5.72% | +16.76% | +30.84% | 2.22 B USD | ||
| 1951 | ZBIO Zenas BioPharma, Inc. - Common Stock | 32.97 USD | -0.48% | +0.27% | +6.05% | +24.60% | 2.15 B USD | ||
| 1953 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.12 USD | -1.04% | -2.18% | +8.85% | +35.12% | 2.14 B USD |